NM_012092.4:c.501+354A>G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_012092.4(ICOS):c.501+354A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.293 in 152,002 control chromosomes in the GnomAD database, including 7,151 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.29 ( 7151 hom., cov: 32)
Consequence
ICOS
NM_012092.4 intron
NM_012092.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.42
Publications
6 publications found
Genes affected
ICOS (HGNC:5351): (inducible T cell costimulator) The protein encoded by this gene belongs to the CD28 and CTLA-4 cell-surface receptor family. It forms homodimers and plays an important role in cell-cell signaling, immune responses, and regulation of cell proliferation. [provided by RefSeq, Jul 2008]
ICOS Gene-Disease associations (from GenCC):
- common variable immunodeficiencyInheritance: AD, AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- immunodeficiency, common variable, 1Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.409 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ICOS | NM_012092.4 | c.501+354A>G | intron_variant | Intron 3 of 4 | ENST00000316386.11 | NP_036224.1 | ||
| ICOS | XM_047444022.1 | c.504+354A>G | intron_variant | Intron 3 of 4 | XP_047299978.1 | |||
| ICOS | XR_007073112.1 | n.553+354A>G | intron_variant | Intron 3 of 5 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.293 AC: 44515AN: 151886Hom.: 7118 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
44515
AN:
151886
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.293 AC: 44603AN: 152002Hom.: 7151 Cov.: 32 AF XY: 0.293 AC XY: 21795AN XY: 74334 show subpopulations
GnomAD4 genome
AF:
AC:
44603
AN:
152002
Hom.:
Cov.:
32
AF XY:
AC XY:
21795
AN XY:
74334
show subpopulations
African (AFR)
AF:
AC:
17156
AN:
41428
American (AMR)
AF:
AC:
4438
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
AC:
825
AN:
3466
East Asian (EAS)
AF:
AC:
1023
AN:
5182
South Asian (SAS)
AF:
AC:
1651
AN:
4822
European-Finnish (FIN)
AF:
AC:
2398
AN:
10582
Middle Eastern (MID)
AF:
AC:
82
AN:
294
European-Non Finnish (NFE)
AF:
AC:
16239
AN:
67948
Other (OTH)
AF:
AC:
620
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1566
3132
4697
6263
7829
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
452
904
1356
1808
2260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1082
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.